BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 21968111)

  • 1. In vitro insulin secretion by pancreatic tissue from infants with diazoxide-resistant congenital hyperinsulinism deviates from model predictions.
    Henquin JC; Nenquin M; Sempoux C; Guiot Y; Bellanné-Chantelot C; Otonkoski T; de Lonlay P; Nihoul-Fékété C; Rahier J
    J Clin Invest; 2011 Oct; 121(10):3932-42. PubMed ID: 21968111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations.
    Pinney SE; MacMullen C; Becker S; Lin YW; Hanna C; Thornton P; Ganguly A; Shyng SL; Stanley CA
    J Clin Invest; 2008 Aug; 118(8):2877-86. PubMed ID: 18596924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KATP channel mutations in congenital hyperinsulinism.
    Saint-Martin C; Arnoux JB; de Lonlay P; Bellanné-Chantelot C
    Semin Pediatr Surg; 2011 Feb; 20(1):18-22. PubMed ID: 21185999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxide-unresponsive congenital hyperinsulinism.
    Bellanné-Chantelot C; Saint-Martin C; Ribeiro MJ; Vaury C; Verkarre V; Arnoux JB; Valayannopoulos V; Gobrecht S; Sempoux C; Rahier J; Fournet JC; Jaubert F; Aigrain Y; Nihoul-Fékété C; de Lonlay P
    J Med Genet; 2010 Nov; 47(11):752-9. PubMed ID: 20685672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diazoxide-unresponsive congenital hyperinsulinism in children with dominant mutations of the β-cell sulfonylurea receptor SUR1.
    Macmullen CM; Zhou Q; Snider KE; Tewson PH; Becker SA; Aziz AR; Ganguly A; Shyng SL; Stanley CA
    Diabetes; 2011 Jun; 60(6):1797-804. PubMed ID: 21536946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Knudson's two-hit model and timing of somatic mutation may account for the phenotypic diversity of focal congenital hyperinsulinism.
    Giurgea I; Sempoux C; Bellanné-Chantelot C; Ribeiro M; Hubert L; Boddaert N; Saudubray JM; Robert JJ; Brunelle F; Rahier J; Jaubert F; Nihoul-Fékété C; de Lonlay P
    J Clin Endocrinol Metab; 2006 Oct; 91(10):4118-23. PubMed ID: 16882742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Congenital hyperinsulinism in newborn and infant].
    Giurgea I; Ribeiro MJ; Boddaert N; Touati G; Robert JJ; Saudubray JM; Jaubert F; Bellanné-Chantelot C; Brunelle F; Nihoul-Fékété C; de Lonlay P
    Arch Pediatr; 2005 Nov; 12(11):1628-35. PubMed ID: 16198094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-inheritance of two ABCC8 mutations causing an unresponsive congenital hyperinsulinism: clinical and functional characterization of two novel ABCC8 mutations.
    Faletra F; Snider K; Shyng SL; Bruno I; Athanasakis E; Gasparini P; Dionisi-Vici C; Ventura A; Zhou Q; Stanley CA; Burlina A
    Gene; 2013 Mar; 516(1):122-5. PubMed ID: 23266803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro recovery of ATP-sensitive potassium channels in β-cells from patients with congenital hyperinsulinism of infancy.
    Powell PD; Bellanné-Chantelot C; Flanagan SE; Ellard S; Rooman R; Hussain K; Skae M; Clayton P; de Lonlay P; Dunne MJ; Cosgrove KE
    Diabetes; 2011 Apr; 60(4):1223-8. PubMed ID: 21411514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of ABCC8 and KCNJ11 gene mutations and phenotypes in Korean patients with congenital hyperinsulinism.
    Park SE; Flanagan SE; Hussain K; Ellard S; Shin CH; Yang SW
    Eur J Endocrinol; 2011 Jun; 164(6):919-26. PubMed ID: 21422196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Destabilization of ATP-sensitive potassium channel activity by novel KCNJ11 mutations identified in congenital hyperinsulinism.
    Lin YW; Bushman JD; Yan FF; Haidar S; MacMullen C; Ganguly A; Stanley CA; Shyng SL
    J Biol Chem; 2008 Apr; 283(14):9146-56. PubMed ID: 18250167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of neonatal hyperinsulinism.
    Giurgea I; Bellanné-Chantelot C; Ribeiro M; Hubert L; Sempoux C; Robert JJ; Blankenstein O; Hussain K; Brunelle F; Nihoul-Fékété C; Rahier J; Jaubert F; de Lonlay P
    Horm Res; 2006; 66(6):289-96. PubMed ID: 17003566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital hyperinsulinism in Brazilian neonates: a study of histology, KATP channel genes, and proliferation of β cells.
    Lovisolo SM; Mendonça BB; Pinto EM; Manna TD; Saldiva PH; Zerbini MC
    Pediatr Dev Pathol; 2010; 13(5):375-84. PubMed ID: 20482375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype-phenotype correlations in children with congenital hyperinsulinism due to recessive mutations of the adenosine triphosphate-sensitive potassium channel genes.
    Henwood MJ; Kelly A; Macmullen C; Bhatia P; Ganguly A; Thornton PS; Stanley CA
    J Clin Endocrinol Metab; 2005 Feb; 90(2):789-94. PubMed ID: 15562009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABCC8 (SUR1) and KCNJ11 (KIR6.2) mutations in persistent hyperinsulinemic hypoglycemia of infancy and evaluation of different therapeutic measures.
    Darendeliler F; Fournet JC; Baş F; Junien C; Gross MS; Bundak R; Saka N; Günöz H
    J Pediatr Endocrinol Metab; 2002; 15(7):993-1000. PubMed ID: 12199344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carriers of an inactivating beta-cell ATP-sensitive K(+) channel mutation have normal glucose tolerance and insulin sensitivity and appropriate insulin secretion.
    Huopio H; Vauhkonen I; Komulainen J; Niskanen L; Otonkoski T; Laakso M
    Diabetes Care; 2002 Jan; 25(1):101-6. PubMed ID: 11772909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperinsulinism of infancy: the regulated release of insulin by KATP channel-independent pathways.
    Straub SG; Cosgrove KE; Ammälä C; Shepherd RM; O'Brien RE; Barnes PD; Kuchinski N; Chapman JC; Schaeppi M; Glaser B; Lindley KJ; Sharp GW; Aynsley-Green A; Dunne MJ
    Diabetes; 2001 Feb; 50(2):329-39. PubMed ID: 11272144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative evaluation of infants with focal or diffuse congenital hyperinsulinism by intravenous acute insulin response tests and selective pancreatic arterial calcium stimulation.
    Stanley CA; Thornton PS; Ganguly A; MacMullen C; Underwood P; Bhatia P; Steinkrauss L; Wanner L; Kaye R; Ruchelli E; Suchi M; Adzick NS
    J Clin Endocrinol Metab; 2004 Jan; 89(1):288-96. PubMed ID: 14715863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of recessive and dominant congenital hyperinsulinism due to mutation(s) in the ABCC8/KCNJ11 genes encoding the ATP-sensitive potasium channel in the pancreatic beta cell.
    Oçal G; Flanagan SE; Hacihamdioğlu B; Berberoğlu M; Siklar Z; Ellard S; Savas Erdeve S; Okulu E; Akin IM; Atasay B; Arsan S; Yağmurlu A
    J Pediatr Endocrinol Metab; 2011; 24(11-12):1019-23. PubMed ID: 22308858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism.
    Kapoor RR; Flanagan SE; Arya VB; Shield JP; Ellard S; Hussain K
    Eur J Endocrinol; 2013 Apr; 168(4):557-64. PubMed ID: 23345197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.